Introduction
The genus Flavivirus includes important human pathogens e.g. yellow fever virus, dengue virus, Zika virus and West Nile virus (WNV). Flavivirus virions are enveloped particles formed by three structural proteins: envelope (E), membrane (M) and core (C).
Capsidless subviral particles (SVPs) self-assemble and are released from cell lines expressing E and the glycoprotein precursor of M (prM) of flaviviruses (Blazevic et al., 2016; Hanna et al., 2005; Inagaki et al., 2016; Makino et al., 2014; Ohtaki et al., 2010; Op De Beeck et al., 2003; Qiao et al., 2004; Yoshii et al., 2012) . Flavivirus-like particles (VLPs) consist of E, M, C proteins and a subgenomic replicon (Pierson et al., 2006) . Both SVPs and VLPs are replication-incompetent virus particles, however, they undergo the same maturation process as whole virions and are thus capable of fusing to target cells (Pierson and Diamond, 2013; Schalich et al., 1996) . Therefore, SVPs and VLPs have been previously used as antigens in serosurveys and for immunization (Inagaki et al., 2016; Ohtaki et al., 2010; Qiao et al., 2004) , and have also been applied to the establishment of model systems for the investigation of cellular entry and extracellular release of virions (Blazevic et al., 2016; Hanna et al., 2005; Kobayashi et al., 2016; Makino et al., 2014; Op De Beeck et al., 2003; Phongphaew et al., 2017; Pierson et al., 2006; Yoshii et al., 2012) .
The split luciferase complementation assays are a well-characterized approach to study protein-protein interactions. Recently, Dixon et al. developed a novel luciferase complementation assay by splitting the NanoLuc (Nluc) luciferase protein into two subunits and optimizing them (Dixon et al., 2016) ; which are referred to as smBiT and LgBiT by the manufacturer (Promega, Madison, WI). SmBiT is an 11 amino acid peptide with low binding affinity for LgBiT and is therefore suitable for protein interaction assays by fusion to proteins of interest (Dixon et al., 2016) . Through the screen of smBiT, "peptide 86" was 4 identified which consists of 11 amino acids with high binding affinity for LgBiT and shows spontaneous complementation. Peptide 86 is referred to as HiBiT (Promega).
The purpose of the present study was the establishment of a simple and sensitive method for the analysis of viral entry and release using SVPs and VLPs with an Nluc luciferase complementation assay. We have generated SVPs and VLPs harboring HiBiT in the viral particles, which we term SVP-HiBiT and VLP-HiBiT, respectively. To validate the experimental utility of SVP-HiBiT and VLP-HiBiT, we have examined these properties in cellular entry and release experiments.
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Materials and Methods
Cell culture
293T cells were propagated in high-glucose Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. A549 cells (RIKEN BRC, Tsukuba, Japan) and Vero cells (JCRB Cell Bank, Osaka, Japan) were propagated in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum.
Plasmids
Plasmids pCMV-SVP expressing prM and E, and pCXSN-C expressing C of WNV 6-LP strain were constructed as described previously (Phongphaew et al., 2017) . Plasmid pCMV-SVP-HiBiT carrying HiBiT flanked by GS linker GSSGGSSGVSGWRLFKKISGSSGGSSG (the HiBiT sequence is underlined) was constructed by inverse PCR using pCMV-SVP as a template. Plasmid pCXSN-C-HiBiT was constructed by adding a GS linker and HiBiT, GSSGGSSGVSGWRLFKKIS, at the C terminus of C protein by inverse PCR using pCXSN-C. The WNV replicon plasmid, pWNIIrep-GFP, was kindly provided by Dr. Doms (Pierson et al., 2006) Camarillo, CA). Anti-β-actin polyclonal antibody conjugated with horseradish peroxidase (PM053-7, MBL, Nagoya, Japan) was used as a loading control antibody. Immune complexes were detected with Immobilon western chemiluminescent HRP substrate (Merck Millipore) and VersaDoc MP 5000 imaging system.
Quantification of the amount of SVPs
SVPs were quantified by sandwich enzyme-linked immunosorbent assay (ELISA) using anti-flavivirus E protein monoclonal antibody clone 402 (kindly provided by Kanonji
Institute of the Research Foundation for Microbial Diseases of Osaka University, Kagawa, Japan) as described previously (Makino et al., 2014; Takahashi et al., 2009 ). For quantification of HiBiT-tagged SVPs, the culture supernatants or fractions containing SVPs were harvested and mixed with LgBiT protein, Nano-Glo luciferase assay buffer and Nano-Glo luciferase assay substrate (Promega) on a 96 well black plate for 10 min.
Luminescence was detected on a luminometer (GloMax-Multi detection system, Promega).
Sucrose gradient sedimentation analysis
After incubation with or without 1% Triton X-100 for 30 min at 4°C, SVPs were overlaid onto 10-50% (w/v) discontinuous sucrose gradient in PBS (−) and ultracentrifuged using a SW41 rotor (Beckman Coulter) at 4°C for 14 h at 247,606 g. Fractions (500 μl each) were carefully collected from the upper phase and SVPs in each fraction were quantified as described above. HiBiT-tagged SVPs in the supernatants were quantified as described above. The 
Statistical analyses
One-way analysis of variance (ANOVA) with Dunnett's test was used to determine statistical significance.
Results
Generation and detection of WNV SVPs tagged with HiBiT
The flavivirus E protein consists of a large ectodomain and two small transmembrane domains (Pierson and Diamond, 2013; Zhang et al., 2003) . We introduced the HiBiT amino acid sequence, VSGWRLFKKIS, flanked with GS linker between two transmembrane domains of WNV E protein and obtained the plasmid, pCMV-SVP-HiBiT (Fig. 1A) .
Therefore, HiBiT is predicted to be localized in the interior of the viral envelope. To generate WNV SVPs tagged with HiBiT (SVP-HiBiT), 293T cells were transfected with pCMV-SVP-HiBiT. The expression of E and prM protein was confirmed on 293T cells by immunoblotting with anti-WNV E and M antibodies, respectively (Fig. 1B) . E protein fused with HiBiT immobilized on the blotting membrane was also found to bind to LgBiT protein and exhibited luminescence following treatment with LgBiT protein and luciferase substrate (Fig. 1B) . The luminescence was specifically observed from the supernatant of cells transfected with pCMV-SVP-HiBiT, increasing in a time-dependent manner, when the supernatant was incubated with LgBiT protein and luciferase substrate (Fig. 1C) , indicating the extracellular secretion of E protein with HiBiT.
To assess the physiological properties of the secreted E protein tagged with HiBiT isolated from the supernatant, the supernatant was concentrated and subjected to sucrose gradient sedimentation analysis. E protein tagged with HiBiT, as well as non-tagged E protein, peaked in the 40% sucrose fraction ( Figs. 2A and 2B ). Disruption of membrane integrity by treatment with Triton X-100 resulted in a shift of the peak to low-density fractions. These sedimentation patterns were similar to those of flavivirus SVPs (Inagaki et al., 2016; Makino et al., 2014) . Taken (Fig. 3A) . The serially diluted SVP-HiBiT was also subjected to the luciferase assay by mixing with LgBiT protein and substrate. Luminescence correlated with the dilution of SVP-HiBiT over a broad dynamic range (Fig 3B) . These results demonstrate that the luciferase assay of SVP-HiBiT could represent a more quantitative measurement of SVPs than traditional antigen-capture ELISA approaches.
We have previously shown that the small GTPase Rab11 is involved in the trafficking and release of WNV virions . To examine whether the budding of SVP-HiBiT follows the same pathway of infectious WNV virions, we measured the extracellular release of SVP-HiBiT on Rab11-depleted cells. The expression of Rab11 was markedly decreased by co-transfection with two different combinations of siRNAs targeting Rab11a and Rab11b (Rab11a+b KD1 and KD2) (Fig. 3C ). Control and Rab11-depleted cells were transfected with pCMV-SVP-HiBiT and the culture supernatants were subjected to the luciferase assay. The luciferase signals from the supernatant of Rab11-depleted cells were significantly lower than those of mock-transfected cells (Fig. 3D ). This result suggests that the extracellular release of SVPs was inhibited by the depletion of Rab11, corresponding to the previous study using infectious whole virus . LgBiT was confirmed by immunoblotting with an antibody against Nluc that cross-reacts with LgBiT (Fig. 4C) . The inoculation of VLP-HiBiT with substrate showed a gradual increase in luminescence and the signal peaked at 30 min, while the luminescence signals did not change following addition of substrate only (Fig. 4D) . The luminescence signal derived from VLP-HiBiT also increased in a dose-dependent manner (Fig. 4E) . We next examined whether the detected luminescence corresponds to the cellular entry of VLP-HiBiT. It has been previously reported that the monoclonal antibody clone 3.91D
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targeting the WNV E protein neutralizes WNV infection (Frost et al., 2012) . Indeed, pretreatment of VLP-HiBiT with the monoclonal antibody 3.91D, but not an isotype control antibody, significantly reduced luminescence signal in the Vero-LgBiT (Fig. 4F) .
Flaviviruses attach to cell surfaces and then enter into cells via clathrin-mediated endocytosis (Chu and Ng, 2004; Pierson and Diamond, 2013) . Dextran sulfate, a soluble glycosaminoglycan, inhibits the attachment and subsequent entry of flaviviruses (Su et al., 2001; Talarico et al., 2005) . Dynasore is a dynamin inhibitor and blocks endocytosis, including the infectious entry of flaviviruses (Kalia et al., 2013; Piccini et al., 2015) . Pitstop 2 is a selective clathrin inhibitor and has been used to block viral entries via clathrin-mediated endocytosis (Garrison et al., 2013; von Kleist et al., 2011) . Treatment with all three inhibitors significantly decreased the luminescence in Vero-LgBiT cells infected with VLP-HiBiT (Fig. 4G) , and no cytotoxicity was observed under the assay conditions (Fig. 4H) . These results indicate that inoculation of VLP-HiBiT to
LgBiT-expressing cells emits luminescence, which is dependent upon the cellular attachment and subsequent entry of VLP-HiBiT.
Discussion
Reporter genes (Fig. 3D) , which is required for the efficient extracellular release of WNV . As various flavivirus SVPs have been used in previous studies (Blazevic et al., 2016; Hanna et al., 2005; Op De Beeck et al., 2003; Yoshii et al., 2012) , the SVP-HiBiT represents a useful tool for the analysis of virion release.
Other studies have employed virus-like particles (VLPs) harboring a subgenomic replicon with a reporter gene expression cassette to estimate viral entry by quantifying reporter gene expression. As this assay method requires stable transcription and translation of the reporter gene from the endocytosed VLPs, in some cases, it has been difficult to evaluate the signal decrease due to the inhibition of VLP entry or gene expression steps (Phongphaew et al., 2017) . It is also laborious and prone to error to count the number of fluorescent-labeling VLPs in cells under microscopy. In Fig. 4 , we developed a VLP-HiBiT entry assay using LgBiT-expressing cells. Theoretically, the luminescence is emitted by direct interaction between the LgBiT protein and HiBiT-tagged C protein after the membrane fusion of VLP-HiBiT. Indeed, the luminescence was specifically observed in
LgBiT-expressing cells infected with VLP-HiBiT under live-cell conditions and the signal was dependent on the endocytic entry of VLP-HiBiT. This assay can therefore also be used as a model system for the analysis of viral entry steps.
Previous studies have generated VLPs and infectious viral particles fused with whole firefly luciferase for the quantification of retroviral entry and release steps (Kolokoltsov and Davey, 2004; Saeed et al., 2006; Sakuragi et al., 2006) . Unlike the larger whole luciferase proteins, such as firefly luciferase and NLuc (550 and 171 amino acids, respectively), HiBiT consists of only 11 amino acids and would be predicted to be less likely to interfere with the maturation and activity of viral proteins. Although WNV is a biosafety level-3 agent and requires a containment laboratory to handle; SVPs and VLPs cause non-productive infection and can therefore be used in a conventional biosafety level-2 laboratory. Taken together and considering these simple, time-saving and quantitative properties of the assay system using SVP-HiBiT and VLP-HiBiT, it will be directly amenable to high-throughput screening to identify host and pathogen-derived factors implicated in viral entry and release steps. 
